QMSMEDI Q4 FY26 Earnings Call Transcript & Analysis
Revenue ₹173 cr (+11% YoY); EBITDA ₹26 cr; PAT ₹12 cr. Revenue from operations increased to INR172.9 crores, up 11% YoY.
Read full transcript & analysis
Every earnings call for QMSMEDI — management tone, guidance, KPIs and promise tracking, quarter by quarter.
QMSMEDI · 3 transcripts · Healthcare · latest Q4 FY26QMS Medical Allied Services Limited has 3 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
Revenue ₹173 cr (+11% YoY); EBITDA ₹26 cr; PAT ₹12 cr. Revenue from operations increased to INR172.9 crores, up 11% YoY.
Read full transcript & analysisQ2 Net Revenue from Operations ₹45 cr (+20% YoY); Q2 EBITDA ₹7 cr; Q2 EBITDA Margin 15.5%. Q2 FY26 Net Revenue from operations stood at ₹44.7 Crores, reflecting a 20% YoY growth.
Read full transcript & analysisRevenue ₹46 cr (+53% YoY); EBITDA ₹7 cr (+37% YoY); PAT ₹3 cr (+31% YoY). Revenue of ₹46.5 crores, highest ever for Q1, up 53% YoY.
Read full transcript & analysis